ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma - Mensali, Nadia (Department of Cellular Therapy. Oslo University Hospital) ; Köksal, Hakan (Oslo University Hospital (Oslo, Noruega)) ; Joaquina, Sandy (Oslo University Hospital (Oslo, Noruega)) ; Wernhoff, Patrick (Oslo University Hospital (Oslo, Noruega)) ; Casey, Nicholas P. (Oslo University Hospital (Oslo, Noruega)) ; Romecín, Paola Alejandra (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Panisello, Carla (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Rodríguez, René (Instituto de Salud Carlos III) ; Vimeux, Lene (Université de Paris) ; Juzeniene, Asta (Oslo University Hospital (Oslo, Noruega)) ; Myhre, Marit R. (Oslo University Hospital (Oslo, Noruega)) ; Fåne, Anne (Oslo University Hospital (Oslo, Noruega)) ; Castilla-Ramirez, Carolina (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Maggadottir, Solrun Melkork (Oslo University Hospital (Oslo, Noruega)) ; Duru, Adil Doganay (Nova Southeastern University) ; Georgoudaki, Anna-Maria (Department of Oncology-Pathology. Karolinska Institutet) ; Grad, Iwona (Oslo University Hospital (Oslo, Noruega)) ; Maturana, Andrés Daniel (Nagoya University) ; Gaudernack, Gustav (Oslo University Hospital (Oslo, Noruega)) ; Kvalheim, Gunnar (Department of Cellular Therapy. Oslo University Hospital) ; Carcaboso, Angel M. (Institut de Recerca Sant Joan de Déu) ; De Álava, Enrique (Universidad de Sevilla) ; Donnadieu, Emma (Université de Paris) ; Bruland, Øyvind S (University of Oslo) ; Menendez, Pablo (Institut Germans Trias i Pujol. Institut de Recerca contra la Leucèmia Josep Carreras) ; Inderberg, Else Marit (Oslo University Hospital (Oslo, Noruega)) ; Wälchli, Sébastien (Oslo University Hospital (Oslo, Noruega))
 
Comments (0) | Reviews (0)
Be the first to review this document.

Add review

Rate this article:
Give a title to your review:
Write your review:
Note: you have not defined your nickname.
N/D will be displayed as the author of this comment.